PhaseBio Pharmaceuticals, Inc. (PHAS)

Investing Cash Flow

-$2.40M

TTM · Period ending: · USD

PHAS logo

PHAS Investing Cash Flow

Latest reported-$2.40M
PHAS TTM Cash from Investing (-$177.00K → -$2.40M)
High-resolution chart · PNG

PHAS investing cash flow history

Trailing twelve months (TTM) · USD. Each value covers four complete reported quarters.

PhaseBio Pharmaceuticals, Inc. Investing Cash Flow — Trailing twelve months (TTM) (USD)
Period endingInvesting Cash Flow (USD)
-2,401,000
-2,595,000
-2,679,000
-1,078,000
-618,000
-887,000
-1,412,000
-1,493,000
-1,710,000
-1,534,000
-960,000
-912,000
-520,000
-197,000
-119,000
-43,000
-177,000
Data is provided for informational purposes only and does not constitute investment advice. Past performance is not indicative of future results.